Lv1
46 积分 2023-02-17 加入
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial—Pembrolizumab Low dose in Addition to NACT in TNBC)
11天前
已完结
Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial)
11天前
已完结
Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
1个月前
已完结
Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)
1个月前
已完结
Lymph Node Dissection in Neoadjuvant Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Real-world Study
3个月前
已关闭
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
4个月前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
5个月前
已完结
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
5个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
5个月前
已完结
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
6个月前
已完结
皖公网安备34019202002308
